AXRX OTC
Amexdrug Corporation
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -99.9%
5Y: -99.6%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$27K
+122.7% ▲
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
$27K
+122.7% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$2K
-145.0% ▼
Net Change in Cash
$17K
+198.4% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2015 | FY2016 | FY2017 |
|---|---|---|---|
| — Operating Activities — | |||
| Net Income | $100K | $74K | $111K |
| Depreciation & Amort. | $9K | $8K | $7K |
| Stock-Based Comp. | $0 | $0 | $0 |
| Change in Working Capital | -$109K | -$200K | -$93K |
| Other Non-Cash Items | $99K | $312K | -$96K |
| Operating Cash Flow | $18K | -$121K | $27K |
| — Investing Activities — | |||
| Capital Expenditures | -$800 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 |
| Investment Sales | $2K | $0 | $0 |
| Other Investing | $0 | $0 | $0 |
| Investing Cash Flow | $780 | $0 | $0 |
| — Financing Activities — | |||
| Net Debt Issuance | $46K | $105K | -$8K |
| Stock Repurchased | -$1K | -$928 | -$2K |
| Dividends Paid | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $0 |
| Financing Cash Flow | $45K | $104K | -$11K |
| Net Change in Cash | $63K | -$17K | $17K |
| Cash End of Period | $236K | $219K | $235K |
| Free Cash Flow | $17K | -$121K | $27K |